Overview

Cellular Aging and Neurobiology of Depression Study

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
We are conducting an eight week longitudinal study to learn if blood levels of certain naturally occurring compounds and genetic markers differ between patients with depression and healthy adults who are not depressed, and if any such differences relate to memory performance, mood, and neurobiology. We will do this by comparing the unmedicated depressed patients with matched healthy controls at baseline and then following the depressed patients over the course of eight weeks of standardized antidepressant treatment to gauge which baseline abnormalities normalize over the course of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
Treatments:
Serotonin
Serotonin Uptake Inhibitors